$14.30
-1.34-8.57%
At close: Nov 13, 4:00 PM EST
$14.30
N/A
After Hours: Nov 13, 4:00 PM EST

The average analyst price target for Lyell Immunopharma is $30.88, 115.9% above the current price. Of 7 analysts, 6 rate it Buy and 1 Sell. Targets range from $10 to $44. The latest change came on Nov 13, 2026, when HC Wainwright & Co. lowered its price target on Lyell Immunopharma from $45 to $39 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months